Table 1.

Baseline characteristics

	Non-DILI cohort (n=1589) (%)	DILI Cohort (n=81) (%)	P value
Median age, years (range)	60.3 (15–90)	59.8 (19–81)	0.9
Sex			0.6
Male	725 (46)	34 (42)
Female	864 (54)	47 (58)
Type of neoplasms			NA
Gastrointestinal	343 (22)	16 (20)
Lung Cancer	257 (16)	12 (15)
Gynecologic	229 (14)	18 (22)
Breast Cancer	157 (10)	6 (7)
Hematologic	90 (6)	4 (5)
Genitourinary	152 (10)	11 (14)
Other	361 (23)	14 (17)
Type of treatment			0.9
Targeted therapy	672 (42)	35 (43)
Immunotherapy	795 (50)	42 (52)
Cytotoxic	44 (3)	2 (3)
Other	12 (1)	0
Combination of classes	66 (4)	2 (3)

DILI, drug-induced liver injury; NA, not applicable; y, years.